Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus sevoflurane for cerebral autoregulation during robotic prostate surgery
ACTRN12619000548134Phase 4Completed
- Sponsor
- Sydney Local Health District
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in prostate cancer (PCa) comparing Propofol maintenance with Sevoflurane maintenance (2 arms). Started May 2019; status: completed.
02
Drugs
propofolsevoflurane
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on ACTRN12619000548134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000548134.